A case report and focused literature review of d-penicillamine and severe neutropenia: A serious toxicity from a seldom-used drug

N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Prescribing d-penicillamine for Wilson's disease must be accompanied by vigilant monitoring, including a complete blood cell count with differential. For most, this should occur once or twice weekly during the first month of therapy and during periods of dose escalation, then every two weeks for six additional months, then monthly.

Cite

CITATION STYLE

APA

Pitman, S. K., Huynh, T., Bjarnason, T. A., An, J., & Malkhasyan, K. A. (2019). A case report and focused literature review of d-penicillamine and severe neutropenia: A serious toxicity from a seldom-used drug. Clinical Case Reports, 7(5), 990–994. https://doi.org/10.1002/ccr3.2125

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free